LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked ...

There has been an increase in fabricated references used in medical papers, according to a research letter published in the May 9 issue of The Lancet. Maxim Top ...

May 14, 2026Biodexa issues letter to ShareholdersBiodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage ...

Investigators found an association between political ideology and clinical trial skepticism, with conservative identification corresponding to higher odds of trial skepticism.

We read with interest the letter by Kwok Chiu Chang and appreciate the potential implications they raise for individuals in settings in which rapid, reliable, and complete drug susceptibility testing ...

An investigation concluded that Yale School of Medicine favored Black and Hispanic applicants. The Justice Department sent ...

Broyhill Equity Composite declined 6.0% in Q1 2026, lagging global benchmarks. Read the full analysis for insights on ...

Editorial questions why historical presidents faced no accountability for devastating military actions while Trump faces ...

Details Success of Pacira's 5x30 Strategy and Solid First Quarter 2026 Results Reiterates Board's Unanimous Recommendation that Stockholders Vote "FOR" the Election of Pacira's Highly Qualified Nomine ...

FDA’s final SIUU guidance loosens some off-label communication rules, but drugmakers still face strict compliance demands to ...

Orphan medical device makers should be deliberate in their questions to expert panels and ensure their post-market clinical ...

Makary’s time as FDA head brought a series of moves designed to speed up the regulatory process and bring greater transparency to the pathway to approval. In February, Makary and top deputy Vinay ...